Loading clinical trials...
Loading clinical trials...
Zekai Tahir Burak Maternity Teaching Hospital, Ankara/Turkey
Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Lactobacillus reuteri was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic Lactobacillus reuteri in reducing the candida colonization and infection in very low birth weight infants.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology
Ankara, Turkey (Türkiye)
Start Date
June 1, 2012
Primary Completion Date
April 1, 2013
Completion Date
April 1, 2013
Last Updated
July 16, 2013
300
ACTUAL participants
Lactobacillus reuteri
DIETARY_SUPPLEMENT
Nystatin
DRUG
Lead Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
NCT06965842
NCT00470743
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions